Microdialysis experiments in rodents indicate that ethanol promotes dopamine release predominantly in the nucleus accumbens, a phenomenon that is implicated in the reinforcing effects of drugs of abuse. The aim of the present study was to test the hypothesis in humans that an oral dose of ethanol would lead to dopamine release in the ventral striatum, including the nucleus accumbens. Six healthy subjects underwent two [
INTRODUCTION
Addiction is thought to result in large part from the reinforcing properties of drugs of abuse on brain reward systems, and in particular on mesolimbic dopamine (Koob et al., 1998; Wise, 1996) . Microdialysis studies in rats show that ethanol and other drugs of abuse, such as opiates, nicotine, amphetamine, and cocaine, acutely increase extracellular dopamine levels predominantly in the nucleus accumbens (NAc) (Di Chiara and Imperato, 1988) . The role of NAc dopamine in alcohol self-administration is further supported by reports of changes in consumption following alterations in mesolimbic dopamine neurotransmission (Rassnick et al., 1993; Samson et al., 1993; Nowak et al., 2000) , ethanol self-administration into the ventral tegmental area (Gatto et al., 1994) , and alcohol withdrawal-induced reductions in both dopamine neuron firing and NAc extracellular dopamine concentration Diana et al., 1992) that are reversed by ethanol administration (Weiss et al., 1996) . Alcohol is widely abused by humans; however, no studies have directly investigated the effect of alcohol consumption on the dopamine system. We now present, for the first time in humans, evidence that alcohol consumed orally promotes dopamine release specifically in the NAc.
We measured dopamine release in response to a single-dose administration of alcohol using positron emis-sion tomography (PET) and the dopamine receptor ligand [
11 C]raclopride. We used a two-scan method based on evidence in primates, including combined PET microdialysis studies, that the binding of benzamides such as [
11 C]raclopride is sensitive and proportional to extracellular dopamine concentration in the striatum (Endres et al., 1997; Ginovart et al., 1997; Hartvig et al., 1997; Laruelle et al., 1997; Laruelle, 2000) . This approach has been used in humans to measure the dopamine response to psychostimulants Schlaepfer et al., 1997; Volkow et al., 2001 ) and behavioral tasks (Koepp et al., 1998) . Three recent PET studies have also shown that dopamine release following amphetamine occurs mostly in the ventral striatum and that the amount of dopamine released correlates with self-reported behavioral measures of euphoria or drug wanting (Drevets et al., 2001; Leyton et al., 2002; Martinez et al., 2003) .
MATERIALS AND METHODS
Seven healthy male nonalcoholic moderate drinkers (brief Michigan Alcoholism Screening Test, Pokorny et al., 1972) , age 22 (Ϯ0.6), were recruited from an existent longitudinal cohort (Tremblay et al., 1994) . All subjects who participated had experienced the alcohol dose administered in this study at least twice in a laboratory setting. Data from one of the seven subjects had to be excluded due to excessive motion during the scan. All subjects were free of active or past medical or psychiatric illness. Subjects fasted and abstained from caffeine or tobacco for a minimum of 4 h before each test session. Five of the six subjects were nonsmokers and one was a light smoker (1-2 cigarettes per day). They were also asked to refrain from taking drugs for 7 days and alcohol for 24 h prior to each experimental day. Before each scanning session, subjects underwent screening for drugs of abuse (Triage Panel for Drugs of Abuse, Biosite Diagnostics, San Diego, CA) including alcohol (Alcosensor III intoxicometer, Thomas Instruments, Montreal, QC). All subjects read and signed a consent form approved by the Research and Ethics Committee of the Montreal Neurological Institute.
Subjects participated in two [ 11 C]raclopride PET scans after consumption of alcohol in orange juice or orange juice alone (Fig. 1 ). Subjects were only told about drink content (alcohol or orange juice alone) at the beginning of the session, and they did not come into contact with the drink until the time of consumption. PET data acquisition was performed at the same time of day (between 14:00 and 16:00) on separate days, 1 week apart, and counterbalanced for order of administration of alcohol (three out of six received alcohol on the first day, randomly chosen). Prior to scanning, a venous catheter was inserted in the subject's left arm. Oral consumption of alcohol (1 ml/kg of 95% USP alcohol over 15 min) or alcohol-free mixture started 30 min prior to tracer injection. The dose of alcohol was selected based on previous behavioral experiments showing that it was intoxicating but without significant adverse effects in this population. At the end of consumption, subjects were immediately positioned in the scanner and a 12-min transmission scan was acquired using a 68 Ge source for the purpose of attenuation correction. Following the transmission scan, and 15 min after the end of alcohol consumption, [
11 C]raclopride 10 mCi was injected as a bolus into the antecubital vein, after which PET dynamic acquisition (63 slices, 26 time frames of 60 min total duration) was performed.
Subjects were scanned on the CTI/Siemens ECAT HRϩ PET camera with lead septa removed, with intrinsic resolution 4.8 ϫ 4.8 ϫ 5.6 mm FWHM. Blood samples, for plasma alcohol measurements, were withdrawn from the venous cannula before the initiation of drinking, at tracer injection (15 min after finishing drinking), and every 15 min thereafter. Subjective effects of alcohol, assessed with the Subjective High Assessment Scale (SHAS, Judd et al., 1977; Schuckit et al., 1997) , and heart rate were measured prior to alcohol consumption and throughout the procedure. The SHAS is a visual analog scale that assesses sensations such as feeling high, drunk, and drowsy. In a separate session, prior to the first scan, all subjects completed the tridimensional personality questionnaire (TPQ; Cloninger et al., 1991) . This test assesses three dimensions of personality, including novelty seeking (impulsive, excitable, exploratory temperament), which is thought to depend in significant part on activity in the dopamine pathways (Cloninger, 1994) . For the purpose of anatomical co-registration, subjects also underwent a 1 ϫ 1 ϫ 1 mm anatomical T 1 -weighted MRI of the whole brain using a gradient echo pulse sequence (TR ϭ 9.7 ms, TE ϭ 4 ms, flip angle ϭ 12°, FOV ϭ 250, matrix ϭ 256 ϫ 256).
PET frames were summed across time, co-registered with the corresponding MRI (Woods et al., 1993) , and transformed into standardized stereotaxic space (Talairach and Tournoux, 1988) by means of automated feature-matching to the MNI template (Collins et al., 1994) . Voxelwise [ 11 C]raclopride binding potential (BP) Fig. 1 . Study design. The vertical arrows indicate the time points of blood sampling, subjective mood assessments, and physiological measurements.
was calculated using a simplified reference tissue method (Lammertsma et al., 1996; Gunn et al., 1997) to generate statistical parametric images of the change in binding (Aston et al., 2000) . BP values for each subject were extracted from regions of interest (ROI) manually drawn on the co-registered MRI on the left and right caudate (drawn on transverse slices at Talairach-space z coordinate from ϩ2 to ϩ15 mm), putamen (ϩ2 to ϩ10 mm), ventral putamen (-8 to -4 mm), NAc (-8 to -4 mm), and cerebellum, which was used as the reference region. BP values extracted from ROI during alcohol and control scans were analyzed using a three-way ANOVA for dependent samples [Treatment ϫ ROI ϫ hemisphere]. Sphericity was assessed with the Mauchly test and, when indicated, corrections were made with Greenhouse-Geisser adjustments. When appropriate, least significant difference t-tests, Bonferroni corrected, were applied to determine the significance of regional differences in BP between the alcohol and orange juice conditions. Heart rate during the ascending part of the blood alcohol curve was compared to a baseline taken just prior to the study session. Since one subject exhibited a change in heart rate during the test session with orange juice that was greater than 2 SD from the sample mean, magnitude of heart rate change was analyzed with the nonparametric Wilcoxon matched pairs test. Maximum change in SHAS rating from baseline taken on the same day (⌬ max [SHAS] ) was used to evaluate the subjective effects of alcohol and control drinks. A t-test for paired samples was used to determine the difference between ⌬ max [SHAS] for the alcohol condition and ⌬ max [SHAS] for the control. Stepwise linear regression analysis was used to examine whether percent change in ROI BP could be predicted by changes in heart rate, change in SHAS scores, or TPQ personality ratings.
RESULTS
Screening for drugs of abuse was positive for only one subject (THC and trace cocaine prior to both scan conditions). Therefore, two different analyses were carried out, one excluding the data from this subject. In both cases, receptor parametric mapping identified significant reductions in [
11 C]raclopride BP in bilateral ventral striatum in the alcohol compared to the alcoholfree condition (Fig. 2) . In the statistically generated 
t-map, [
11 C]raclopride BP values were 16.8 Ϯ 16.3% lower on the test day with alcohol, compared to orange juice (t(5) ϭ 2.54, P ϭ 0.05).
Analyses of [ 11 C]raclopride BP values in the a priori defined ROI supported the receptor parametric mapping analyses (Fig. 3) . A treatment ϫ ROI ϫ hemisphere ANOVA yielded a main effect of ROI (F(3,15) ϭ 42.55, P Ͻ 0.001, Greenhouse-Geisser corrected) and a treatment ϫ ROI interaction (F(3,15) ϭ 3.21, P ϭ 0.05). Bonferroni-corrected pairwise comparisons confirmed that alcohol significantly reduced BP in the NAc (P ϭ 0.003) and ventral putamen (P ϭ 0.001) but not in the caudate (P ϭ 0.98) or putamen (P ϭ 0.84). The percent change in [ 11 C]raclopride BP also varied with ROI (F(3,15) ϭ 13,50, P ϭ 0.001). In both the nucleus accumbens (15.0 Ϯ 15.9%) and the ventral putamen (13.7 Ϯ 16.4%), the percent decreases in [ 11 C]raclopride BP were greater than those seen in either the putamen (5.2 Ϯ 17.5%) or caudate nucleus (4.0 Ϯ 16.4%) (P Ͻ 0.01).
The blood alcohol level reached a mean peak of 18.10 (Ϯ1.4) mmol/L (0.0833 gm %) at 30 min after drinking. During the expected ascending phase of the blood alcohol curve (15-30 min post drink) alcohol consumption resulted in small but consistent increases in heart rate (5.47 Ϯ 6 beats/min; t(5) ϭ 1.85, P ϭ 0.12; 6/6 subjects higher during alcohol test, Wilcoxon matched pairs test, z ϭ 2.20; P ϭ 0.028) and self-reported feelings of "high" and "drunkenness" (paired t-test, ⌬ max [SHAS] alcohol vs. ⌬ max [SHAS] orange juice, P Ͻ 0.01). A stepwise linear regression showed that impulsiveness, one of the subscales on the novelty-seeking dimension of the TPQ, and heart rate increase recorded at 30 min (i.e., during the ascending phase of the blood alcohol curve) were the only predictors of BP change in the ventral striatum (r ϭ 0.985; P ϭ 0.005). Neither the subjective intoxication measures nor the peak blood alcohol level correlated with the change in [
11 C]raclopride BP in any region.
DISCUSSION
The observed reduction in [ 11 C]raclopride BP confined to the ventral part of the striatum is indicative of dopamine release specifically in the NAc and ventral putamen in response to alcohol in humans. The ventral specificity of the effect is consistent with three other [ 11 C]raclopride PET studies, in which amphetamine was found to preferentially induce dopamine release in the ventral striatum in humans (Drevets et al., 2001; Leyton et al., 2002; Martinez et al., 2003) . In animals, in vivo microdialysis studies have also shown a propensity for alcohol to induce dopamine release in the ventral striatum. Di Chiara and Imperato (1988) found that ethanol at rewarding doses had an almost 10-fold greater effect on dopamine release in the NAc than in the dorsal caudate. Moreover, low doses of ethanol produce a dose-dependent increase in the firing rate of A10 dopamine neurons in the ventral tegmental area, which project to the ventral striatum . Activation of A9 dopamine neurons, which project to the dorsal striatum, only occurs at 5-fold greater ethanol doses.
While a direct pharmacological effect of alcohol could account for our findings, it is possible that conditioned cues and anticipation also played a role in enhancing dopamine release. In humans, exposure to the odor of alcohol leads to autonomic nervous system activity (Stormark et al., 1995) , and alcohol-related cues have been shown to cause dopamine release in rats previously trained to self-administer alcohol (Katner and Weiss, 1999) . The subjects in our study only learned whether they would receive alcohol or not when they arrived at the lab and they were kept away from the drinks until the start of consumption, thus limiting the potential influence of anticipation in this experiment.
The dorsal and ventral striatum can be separated functionally and anatomically (Moore and Bloom, 1978; Heimer et al., 1982; Haber et al., 2000) . Their dopamine innervations originate in different cell groups in the midbrain and their cortical connections likely account for their different functional roles. The ventral striatum, including the NAc and ventral putamen, belong to the "limbic" cortico-striatal loop that includes the amygdala, hippocampus, orbito-frontal cortex, and cingulate cortex, structures involved in emotional behavior and reward processing. There is much evidence for specific involvement of ventral striatal, or mesolimbic, dopamine in the reinforcing effects of addictive drugs (Wise, 1996; Koob et al., 1998) . It is thought to mediate associative learning, whereby drug-related cues acquire incentive value (Di Chiara et al., 1999) . Conditioned place preference, a laboratory test of conditioned incentive learning, is abolished by lesions or dopamine blockade of the ventral but not dorsal striatum (Everitt et al., 1991; Hiroi and White, 1991) . Our finding of dopamine release confined to the ventral striatum after oral ingestion of an intoxicating dose of alcohol may therefore account at least in part for its addictive properties in humans.
Ethanol most likely acts on dopamine neurons indirectly (Yim et al., 1998) . It potentiates GABA-A receptor function (Weiner et al., 1994) to cause inhibition of GABAergic interneurons in the substantia nigra reticulata , which leads to disinhibition and increased burst firing of dopamine neurons (Grace and Bunney, 1985) . As stated above, A10 neurons projecting to the ventral striatum appear to be more sensitive to these systemic effects of ethanol than A9 dopamine neurons projecting to the dorsal striatum . Opioid peptides may also be involved in the dopamine releasing actions of ethanol (Acquas et al., 1993; Benjamin et al., 1993; .
The level of dopaminergic responsiveness in the NAc has been proposed as a marker of individual vulnerability to drug addiction. Numerous studies in rats have linked the propensity to self-administer drugs to enhanced dopamine release in the NAc in response to psychostimulants or stress (e.g., Piazza et al., 1991; Hooks et al., 1992; Zocchi et al., 1998; Marinelli and White, 2000) , or ethanol (Weiss et al., 1993) . In light of these studies, our finding of a correlation between the change in [
11 C]raclopride BP in response to alcohol and two variables, the alcohol-induced increase in heart rate and the personality trait of impulsiveness, is interesting.
In humans, cardiac response has been hypothesized to be an index of the psychostimulant properties of alcohol and of dopamine activation (Conrod et al., 2001) , and therefore a marker of vulnerability to addiction. Our findings, although in a small number of subjects, lend support to this theory. Moreover, the personality trait of novelty-seeking, of which impulsiveness is one component, has also been linked to both dopamine function (Cloninger, 1994) and to addictive propensity. High scores on the novelty-seeking scale of the TPQ predict later alcoholism (Cloninger et al., 1988) as well as relapse-rate in detoxified alcoholics (Meszaros et al., 1999) . Interestingly, in a previous PET study we found that amphetamine-induced dopamine release also targeted the NAc and correlated with novelty-seeking scores (Leyton et al., 2002 ).
In the current study, we found no correlation between alcohol-induced NAc dopamine release and subjective measures of intoxication. Previously, we similarly found no correlation between amphetamineinduced dopamine release and behavioral effects such as euphoria and excitation (Leyton et al., 2002) . The association between a drug's euphorigenic quality and dopamine release has not been established in humans; similarly, in rats the behavioral significance of increased DA remains a subject of debate. Our failure to find a correlation between subjective effects and DA release likely reflects the fact that alcohol acts on multiple neurotransmitter systems. In particular, the SHAS mostly reflects the sedative effects of alcohol (Conrod et al., 2001) , which are probably not mediated by dopamine.
In conclusion, we showed that alcohol consumed by mouth in intoxicating doses promotes dopamine release in the ventral striatum. The observed relationship between the magnitude of change in [
11 C]raclopride BP, personality, and heart rate increase suggests that the paradigm we have developed could be used to investigate the factors that lead to vulnerability for alcohol dependence.
